MedTrace Logo

Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells

NCT05167552 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-01-19

No results posted yet for this study

Summary

Treatment of patients with allergic rhinitis and chronic polypous rhinosinusitis with olfactory mucosa-derived mesenchymal stem cells

Conditions

  • Allergic Rhinitis
  • Rhinosinusitis Chronic

Interventions

BIOLOGICAL

Olfactory mucosa-derived mesenchymal stem cells

Olfactory mucosa-derived mesenchymal stem cells

OTHER

Standard treatment of type Allergic Rhinitis according to the clinical protocols

Standard treatment of type Allergic Rhinitis according to the clinical protocols

OTHER

Standard treatment of type Chronic Polypous Rhinosinusitis according to the clinical protocols

Standard treatment of type Chronic Polypous Rhinosinusitis according to the clinical protocols

Sponsors & Collaborators

  • The Republican Center for Research and Practice in Otolaryngology

    collaborator UNKNOWN

  • Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

    lead OTHER_GOV

Principal Investigators

  • Natalia Antonevich, Dr · the Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

  • Yulia Eremenko, Prof · The Republican Center for Research and Practice in Otolaryngology

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2023-12-31
Completion
2023-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05167552 on ClinicalTrials.gov